SCH: Quantifying and mitigating demographic biases of machine learning in real world radiology
SCH: Quantifying and mitigating demographic biases of machine learning in real world radiology
批准号:
10818941
负责人:
JEREMIAS SULAM
金额:
$31.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2026-06-30
关键词:
AddressAgeAlgorithmsAnatomyAreaArtificial IntelligenceBindingBreast Cancer DetectionCertificationChest imagingClinical/RadiologicComplementComplexDataData SetDevelopmentDiagnosisDiagnostic ImagingDiseaseDisparityEngineeringEnsureEthicsEvaluationExplosionFutureGenerationsHealthHealth PolicyImageIndividualInstructionKnowledgeLocationMachine LearningMalignant neoplasm of lungMeasuresMedical ImagingMedical centerMedicineMethodologyMethodsModernizationMonitorOutcomePerformancePopulationProceduresProxyPublic Health Applications ResearchRaceRadiology SpecialtyRecommendationResearchSamplingScienceScreening for cancerScreening procedureSeriesSystemTechnologyThoracic RadiographyTimeTrainingUnderrepresented PopulationsValidationaccess disparitiesalgorithmic biasartificial neural networkbiological sexbreast imagingcancer diagnosiscancer imagingclinically relevantdeep neural networkdemographicsdiagnostic accuracydiagnostic tooldisease classificationdisparity reductionhealth disparityhigh riskimaging modalityimprovedlung cancer screeningmachine learning algorithmmachine learning methodmachine learning modelmalignant breast neoplasmnovelpopulation basedprediction algorithmpredictive modelingpreventpublic health relevancereal world applicationscreeningscreening programtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY (See instructions):
The application of modern machine learning algorithms in radiology continues to grow, as these tools
represent potential huge improvements in efficiency, accessibility and accuracy of diagnostic and
screening tools. At the same time, these increasingly complex machine learning models can have biased
predictions against individuals of under-represented demographic groups, potentially perpetuating
pre-existing health disparities. Such fairness concerns are particularly important in public health
applications that focus on large scale population-based screening, as in cancer screening for breast and
lung cancer. In these settings, it is paramount to understand how often machine learning screening
algorithms can be unfair and biased, and how to mitigate these disparities. This proposal will develop
tools to quantify, correct, and analyze the biases of predictive algorithms in relation to different
demographic groups in real world settings. In particular, we will develop analysis and algorithms to
quantify the violation of fairness by a machine learning model in situations where information about the
sensitive attribute itself (such as biological sex, race or age) are not directly observable, and we will
provide algorithms that correct for their worst-case fairness violations. We will analyze our tools under
distribution shifts, whereby differences in populations exist, as is common in large scale cancer screening
programs. This project will also perform inference on the training samples and features most highly
associated with fairness violations, thereby providing guidance on the development of solutions to prevent
biased algorithms in the future. Our tools will be validated on a variety of large real-world radiology
datasets spanning multiple imaging modalities, including general chest X-ray datasets that include lung
cancer diagnoses (CheXpert and MIMIC-CXR), as well as the Emory Breast Cancer Imaging Dataset
(EMBED) and the National Lung Cancer Screening Trial, evaluating and correcting disparities for
predictive algorithms with respect to biological sex (where appropriate), race, and age. The results of this
project will establish critical knowledge about the propensity of machine learning models for medical
imaging diagnosis and cancer screening to be unfair and biased, as well as foundational tools to quantify
and mitigate these biases in these potentially game-changing technologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: